The Emerging Evidence for Immune System Control of Cancer: Engineering the Cure

Brendon “The Emerging Evidence Coventry for Immune System Control of Cancer: Engineering the Cure”

Brendon Coventry is a surgeon at the University of Adelaide’s School of NOVEMBER 10, 2014 Medicine. His special interests are Melanoma Surgery, Breast 12PM- Surgery, Breast Reconstruction and face and neck tumors. 1PM Brendon has a PhD in Cancer Immunology Abstract: and research interests in cancer vaccine Immune system control of cancer has long been promised as a immunotherapies, and viable therapeutic solution, but likewise has remained unproven and sentinel lymph node enigmatic. Recent findings reinforce the tenet that the immune techniques. He is a system is already responding to the cancer within the patient. Research Director of Furthermore, it is capable of clinical effective cancer removal, but is the Australian Melanoma Research being down-regulated to prevent in-vivo intrinsic efficacy. Foundation and has Problematically, using the immunotherapies noted above the had much success in strength and direction of immune stimulation cannot yet be treating metastatic determined, often resulting in serious auto-immunity, including treatment-related deaths. Our work shows that serial monitoring of Beyond inflammatory biomarkers in cancer patients reveals oscillatory behavior, such that the timing of dose administration appears pivotal Center for determining which way the immune response is being driven. 650 E Tyler Mall Tempe, AZ 85287 Goldwater Building Room: GWC505